Therapeutic perspectives on antisense oligonucleotides
Mazza, P.
Bollettino Chimico Farmaceutico 131(10): 355-362
1992
ISSN/ISBN: 0030-0632 PMID: 1296675 Document Number: 390052
Document emailed within 1 workday
Related Documents
Guinot, P.; Temsamani, J. 1998: Antisense oligonucleotides: a new therapeutic approach Pathologie-Biologie 46(5): 347-354De Falco, S.; Boutorine, A.; de Smidt, C.; van Berkel, T.; Saison, E.; Hélène, C.; Le Doan, T. 1991: Utilization of antisense oligonucleotides in vivo: stability and internalization of hydrophobized oligonucleotides Nucleic Acids Symposium Series 24: 157-158
Juliano, R.L.; Yoo, H. 2000: Aspects of the transport and delivery of antisense oligonucleotides Current Opinion in Molecular Therapeutics 2(3): 297-303
Le Doan, T.; Etoré, F.; David, D.F.; Tenu, J.P. 1996: Prospects of a more selective chemotherapy with antisense oligonucleotides Annales de Medecine Interne 147(8): 542-552
Ho, P.T.; Parkinson, D.R. 1997: Antisense oligonucleotides as therapeutics for malignant diseases Seminars in Oncology 24(2): 187-202
Kozlov, V.A.; Sennikov, S.V. 1997: The use of antisense oligonucleotides for modulation of cytokine gene expression Voprosy Meditsinskoi Khimii 43(5): 308-320
Stepkowski, S.M.; Tian, L.; Kloc, M. 1993: Interleukin-2 antisense oligonucleotides inhibit T-cell function Transplantation Proceedings 25(1 Part 1): 125
Uhlmann, E. 2000: Recent advances in the medicinal chemistry of antisense oligonucleotides Current Opinion in Drug Discovery and Development 3(2): 203-213
Barry, E.L.; Gesek, F.A.; Friedman, P.A. 1993: Introduction of antisense oligonucleotides into cells by permeabilization with streptolysin O Biotechniques 15(6): 1016-8 1020
Nakamura, T.Y.; Artman, M.; Rudy, B.; Coetzee, W.A. 1998: Inhibition of rat ventricular IK1 with antisense oligonucleotides targeted to Kir2.1 mRNA American Journal of Physiology 274(3): H892-H900
Keith, F.J.; Bradbury, D.A.; Zhu, Y.M.; Russell, N.H. 1995: Inhibition of bcl-2 with antisense oligonucleotides induces apoptosis and increases the sensitivity of AML blasts to Ara-C Leukemia 9(1): 131-138
Vellón, L.; Cuello, T.; Gargallo, P.; Larripa, I. 2000: Antisense oligonucleotides increase the apoptotic effect of idarubicin in K-562 cell line Medicina 60(1): 143-145
Sommer, W.; Heilig, M. 1999: Antisense oligonucleotides are clinically tested. they inhibit the expression of disease-related genes Lakartidningen 96(4): 348-354
Gnarra, J.R.; Dressler, G.R. 1995: Expression of Pax-2 in human renal cell carcinoma and growth inhibition by antisense oligonucleotides Cancer Research 55(18): 4092-4098
Smetsers, T.F.; van de Locht, L.T.; Pennings, A.H.; Wessels, H.M.; de Witte, T.M.; Mensink, E.J. 1995: Phosphorothioate BCR-ABL antisense oligonucleotides induce cell death, but fail to reduce cellular bcr-abl protein levels Leukemia 9(1): 118-130
Wojcik, W.J.; Swoveland, P.; Zhang, X.; Vanguri, P. 1996: Chronic intrathecal infusion of phosphorothioate or phosphodiester antisense oligonucleotides against cytokine responsive gene-2/IP-10 in experimental allergic encephalomyelitis of lewis rat Journal of Pharmacology and Experimental Therapeutics 278(1): 404-410
Nair, S.K.; Snyder, D.; Gilboa, E. 1996: Cells treated with TAP-2 antisense oligonucleotides are potent antigen-presenting cells in vitro and in vivo Journal of Immunology 156(5): 1772-1780
Kishima, Y.; Yoshida, K.; Enomoto, H.; Yamamoto, M.; Kuroda, T.; Okuda, Y.; Uyama, H.; Nakamura, H. 2002: Antisense oligonucleotides of hepatoma-derived growth factor (HDGF) suppress the proliferation of hepatoma cells Hepato-Gastroenterology 49(48): 1639-1644
Chen, Z.; Fisher, R.J.; Riggs, C.W.; Rhim, J.S.; Lautenberger, J.A. 1997: Inhibition of vascular endothelial growth factor-induced endothelial cell migration by ETS1 antisense oligonucleotides Cancer Research 57(10): 2013-2019
Mahon, F.X.; Ripoche, J.; Pigeonnier, V.; Jazwiec, B.; Pigneux, A.; Moreau, J.F.; Reiffers, J. 1995: Inhibition of chronic myelogenous leukemia cells harboring a BCR-ABL B3A2 junction by antisense oligonucleotides targeted at the B2A2 junction Experimental Hematology 23(14): 1606-1611